Last reviewed · How we verify
Celery Seed
At a glance
| Generic name | Celery Seed |
|---|---|
| Also known as | Apium graveolens Leen |
| Sponsor | University of Guadalajara |
| Drug class | Non-Standardized Food Allergenic Extract [EPC] |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
- Improving sexual desire
- Strengthening prostate problems
- Kidney stones
- Bladder stones
Common side effects
Key clinical trials
- Butylphthalide for Long-term Efficacy in Minor Stroke Study (PHASE3)
- Evaluation of Effects of Dibifree® on Regulation of Blood Sugar and HbA1c in Patients With Type II Diabetes (NA)
- Effect of Celery Seed on the Components of Metabolic Syndrome, Insulin Sensitivity and Insulin Secretion (PHASE2)
- The Efficacy of Amway Uric Acid Lowering Product on Hyperuricemia (NA)
- Randomized Control Trial of Small-Molecule Natural Flavonoids Intervention for Neurodegenerative Diseases (NA)
- Single Arm Clinical Trial of Small Molecule Natural Flavonoid Compounds for Intervention in Neurodegenerative Diseases (NA)
- Improving Protein Intake in Older Adults (NA)
- Efficacy of Myalgesin™ to Support Joint Function in Patients With Knee Osteoarthritis (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Celery Seed CI brief — competitive landscape report
- Celery Seed updates RSS · CI watch RSS
- University of Guadalajara portfolio CI